# PK/PD Study of U-500 Regular Insulin

> **NCT02148250** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 17 (actual)

## Conditions studied

- Type 2 Diabetes
- Insulin Resistance
- High Insulin Requirements

## Interventions

- **DRUG:** U-500 insulin, 100 syringe units
- **DRUG:** U-500 insulin, 200 syringe units

## Key facts

- **NCT ID:** NCT02148250
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02148250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02148250, "PK/PD Study of U-500 Regular Insulin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02148250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*